Helping young children with autism develop language skills
Personalized, Responsive Intervention Sequences for Minimally Verbal Children with Autism (PRISM)
This study is looking for preschool kids aged 3-4 with autism who don’t talk much, and it’s all about finding the best ways to help them learn to speak better by trying out different personalized strategies that change as they grow and respond to treatment.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-10565679 on NIH RePORTER |
What this research studies
This research focuses on preschool children aged 3-4 years with autism spectrum disorder who are minimally verbal. It aims to create personalized intervention strategies that adapt over time based on each child's unique response to treatment. By using a two-stage, 20-week adaptive intervention approach, the project seeks to enhance language development in these children, potentially helping them to become more verbal by school age. The study involves multiple sites to gather diverse data and improve intervention effectiveness.
Who could benefit from this research
Good fit: Ideal candidates for this research are preschool children aged 3-4 years who are diagnosed with autism spectrum disorder and are minimally verbal.
Not a fit: Children who are already verbal or do not have autism spectrum disorder may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve language outcomes for preschoolers with autism, helping them to communicate more effectively.
How similar studies have performed: Previous research has shown promise in using adaptive interventions for language development in older children with autism, but this approach for younger, minimally verbal children is relatively novel.
Where this research is happening
Los Angeles, United States
- University of California Los Angeles — Los Angeles, United States (Active)
Researchers
- Principal investigator: Kasari, Connie L. — University of California Los Angeles
- Study coordinator: Kasari, Connie L.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.